1.
Sadeghi S, Goodarzi A. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective. Dermatol Pract Concept. 2022;12(4):e2022178. doi:10.5826/dpc.1204a178